Alkem Laboratories · NSE: ALKEM · BSE: 539523
Q3 FY20 results · Oct–Dec 2019
Alkem Laboratories reported revenue from operations of ₹2,181.84 crore (up 13.3% from Q3 FY19) and net profit of ₹389.96 crore (up 89.8% from Q3 FY19) for Q3 FY20 (Oct–Dec 2019), on a consolidated basis.
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,181.84 | 1,925.03 | +13.3% | 2,264.03 | −3.6% |
| Other income | 27.86 | 9.35 | +198.0% | 31.42 | −11.3% |
| Total income | 2,209.70 | 1,934.38 | +14.2% | 2,295.45 | −3.7% |
| Profit before tax | 404.61 | 258.06 | +56.8% | 409.86 | −1.3% |
| Net profit for the period | 389.96 | 205.45 | +89.8% | 380.52 | +2.5% |
| Attributable to shareholders of the company | 381.98 | 202.53 | +88.6% | 370.85 | +3.0% |
| EPS, basic (₹) | 31.95 | 16.94 | +88.6% | 31.02 | +3.0% |
| Net margin (%) | 17.9 | 10.7 | 16.8 |
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,596.40 | 1,536.03 | +3.9% | 1,894.65 | −15.7% |
| Other income | 26.75 | 5.75 | +365.2% | 30.59 | −12.6% |
| Total income | 1,623.15 | 1,541.78 | +5.3% | 1,925.24 | −15.7% |
| Profit before tax | 337.80 | 286.92 | +17.7% | 465.29 | −27.4% |
| Net profit for the period | 348.57 | 241.23 | +44.5% | 434.02 | −19.7% |
| EPS, basic (₹) | 29.15 | 20.18 | +44.5% | 36.30 | −19.7% |
| Net margin (%) | 21.8 | 15.7 | 22.9 |
Consolidated
- Filed with BSE
- 07 Feb 2020, 19:37 IST
- Board meeting
- 07 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Feb 2020, 19:37 IST
- Board meeting
- 07 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE